ArticleScientific reports2025
CleanSeqU algorithm for decontamination of catheterized urine 16S rRNA sequencing data.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Methodological bias shapes the interpretation of the urinary microbiome in low-biomass systems.Frontiers in microbiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Contamination in low-biomass samples, such as urine, presents a major challenge for 16S rRNA gene sequencing, as extraneous DNA from reagents and the environment often obscures microbial signals. Existing in silico decontamination algorithms face limitations in accurately identifying and removing these contaminants. To address this issue, we developed CleanSeqU, a novel decontamination algorithm designed to enhance the accuracy of 16S rRNA gene sequencing data for catheterized urine samples. This approach is grounded in the principle that the compositional pattern of potential contaminant taxa remains similar between biological samples and blank controls. Also, the algorithm identifies potential contaminants based on ecological plausibility and custom blacklist. We evaluated CleanSeqU's performance using vaginal microbiome dilution experiments as a proxy for low-biomass urine samples and compared it to the Decontam, Microdecon, and SCRuB algorithm. CleanSeqU consistently outperformed Decontam, Microdecon, and SCRuB across various contamination levels, with superior accuracy, F1-scores, and reduced beta-dissimilarity. CleanSeqU improved specificity and positive predictive value by correctly identifying and removing a higher number of contaminant amplicon sequence variants (ASVs). Furthermore, the reduced alpha diversity in the decontaminated datasets suggests more precise contaminant elimination. With its practical use of a single blank extraction control per batch and adjustable decontamination rules, CleanSeqU provides an efficient and scalable solution that delivers accurate microbial profiles. Our findings highlight its potential to significantly advance urine microbiome research by delivering more accurate microbial profiles.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.